Sing George L

Director

Regeneron Pharmaceuticals, Inc.

US, Tarrytown [HQ]

CIK 1225471

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

26,272

Price per Share :

$703.43

Equivalence :

$18,480,512.96

G

Form 4

26,272 Shares After Transaction

Value : $n/a

$0.0

Transaction Date : 09/04/24
- Footnotes
- Form 4
Footnotes:
No footnote found.
M

Form 4

29,610 Shares After Transaction

Value : $12,238,701.30

$1,379,695.54

Transaction Date : 12/31/24
- Footnotes
- Form 4
Footnotes:
#1 Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.
F

Form 4

27,662 Shares After Transaction

Value : $19,589,951.78

$1,379,554.12

Transaction Date : 12/31/24
- Footnotes
- Form 4
Footnotes:
#1 Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.
A

Form 4

27,828 Shares After Transaction

Value : $n/a

$0.0

Transaction Date : 01/02/25
- Footnotes
- Form 4
Footnotes:
#1 Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.
M

Form 4

26,849 Shares After Transaction

Value : $11,097,497.17

$206,665.00

Transaction Date : 02/08/24
- Footnotes
- Form 4
Footnotes:
No footnote found.

Get PRO Today.

PRO unlocks 17 more insider transactions made by Sing George L

Start Free PRO trial Subscribe to PRO

NASDAQ

United States

Tarrytown

Healthcare

Biotechnology